Randhawa Simrat bought DNTH
November 13, 2025 · Form 4 insider transaction
Randhawa Simrat bought 3,529 shares of Dianthus Therapeutics, Inc. at $17.88 per share, a transaction worth $63.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,529
Price
$17.88
Total value
$63.1K
InsiderRandhawa Simrat
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 13, 2025
Filing dateNovember 14, 2025
Shares owned after91,507
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.